Advertisement

Perspectives on Participation in Clinical Trials Among Individuals With Pain, Depression, and/or Anxiety: An ACTTION Scoping Review

Published:September 21, 2022DOI:https://doi.org/10.1016/j.jpain.2022.09.001

      Highlights

      • Individuals with pain have challenges that affect trial participation.
      • Individuals with depression have challenges that affect trial participation.
      • Assessments of perspectives in underserved or marginalized populations are needed.
      • Trial design should promote facilitators and accommodate barriers.

      Abstract

      For individuals experiencing pain, the decision to engage in clinical trials may be influenced by a number of factors including current and past care, illness severity, physical functioning, financial stress, and caregiver support. Co-occurring depression and anxiety may add to these challenges. The aim of this scoping review was to describe perspectives about clinical trial participation, including recruitment and retention among individuals with pain and pain comorbidities, including depression and/or anxiety. We searched PubMed, CINAHL, PsycINFO, and Cochrane CENTRAL databases. Study features, sample demographics, perspectives, barriers and/or motivations were collected and described. A total of 35 assessments were included in this scoping review with 24 focused on individuals with pain (24/35, 68.6%), 9 on individuals with depression and/or anxiety (9/35, 25.7%), and 2 on individuals with pain and co-occurring depression/anxiety (2/35, 5.7%). Barriers among participants with pain and those with depression included: research team's communication of information, fear of interventional risks, distrust (only among respondents with pain), too many procedures, fear of inadequate treatment, disease-life stressors, and embarrassment with study procedures (more commonly reported in participants with depression). Facilitators in both groups included: altruism and supportive staff, better access to care, and the ability to have outcome feedback (more commonly among individuals with depression). Individuals with pain and depression experience challenges that affect trial recruitment and retention. Engaging individuals with pain within research planning may assist in addressing these barriers and the needs of individuals affected by pain and/or depression.

      Perspective

      This review highlights the need to address barriers and facilitators to participation in clinical trials, including the need for an assessment of perspectives from underserved or marginalized populations.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Ackerman IN
        • Buchbinder R
        • Osborne RH
        Factors limiting participation in arthritis self-management programmes: an exploration of barriers and patient preferences within a randomized controlled trial.
        Rheumatol Oxf Engl England;. 2013; 52: 472-479
        • Bair MJ
        • Robinson RL
        • Katon W
        • Kroenke K
        Depression and pain comorbidity: A literature review.
        Arch Intern Med. 2003; 163: 2433
        • Barnes M
        • Wiles N
        • Morrison J
        • Kessler D
        • Williams C
        • Kuyken W
        • Lewis G
        • Turner K
        Exploring patients’ reasons for declining contact in a cognitive behavioural therapy randomised controlled trial in primary care.
        Br J Gen Pract. 2012; 62: e371-e377
        • Bennett MI
        • Mulvey MR
        • Campling N
        • Latter S
        • Richardson A
        • Bekker H
        • Blenkinsopp A
        • Carder P
        • Closs J
        • Farrin A
        • Flemming K
        • Gallagher J
        • Meads D
        • Morley S
        • O'Dwyer J
        • Wright-Hughes A
        • Hartley S
        Self-management toolkit and delivery strategy for end-of-life pain: The mixed-methods feasibility study.
        Health Technol Assess Winch Engl. 2017; 21: 1-292
        • van den Berg P
        • Kendal S
        • Alderson HV
        • Body R
        An exploration of patients’ experiences of participation in a randomised controlled trial of the Manchester Acute Coronary Syndromes (MACS) decision rule.
        Emerg Med J BMJ Publishing Group;. 2017; 34: 593-598
        • Bondesson E
        • Larrosa Pardo F
        • Stigmar K
        • Ringqvist Å
        • Petersson IF
        • Jöud A
        • Schelin MEC
        Comorbidity between pain and mental illness - Evidence of a bidirectional relationship.
        Eur J Pain. 2018; 22: 1304-1311
        • Bove AM
        • Lynch AD
        • Ammendolia C
        • Schneider M
        Patients’ experience with non-surgical treatment for lumbar spinal stenosis: A qualitative study.
        Spine J. 2017; 18: 639-647
        • Chambers CT
        From evidence to influence: Dissemination and implementation of scientific knowledge for improved pain research and management.
        Pain. 2018; 159: S56-S64
        • Cheung YK
        • Wood D
        • Zhang K
        • Ridenour TA
        • Derby L
        • St Onge T
        • Duan N
        • Duer-Hefele J
        • Davidson KW
        • Kronish I
        • Moise N
        Personal preferences for personalised trials among patients with chronic diseases: an empirical Bayesian analysis of a conjoint survey.
        BMJ Open. 2020; 10e036056
        • Cramer H
        • Salisbury C
        • Conrad J
        • Eldred J
        • Araya R
        Group cognitive behavioural therapy for women with depression: Pilot and feasibility study for a randomised controlled trial using mixed methods.
        BMC Psychiatry. 2011; 11: 82
        • DasMahapatra P
        • Raja P
        • Gilbert J
        • Wicks P
        Clinical trials from the patient perspective: Survey in an online patient community.
        BMC Health Serv Res. 2017; 17: 166
        • Dennin MD
        Enhancing patient engagement in Parkinson's disease mental health research.
        ProQuest Information & Learning. 2020; ([Internet]) (Available from:)
        • Denny E
        • Weckesser A
        • Jones G
        • Bibila S
        • Daniels J
        • Bhattacharya S
        Women's experiences of medical treatment for endometriosis and its impact on PRE-EMPT trial participation: a qualitative study.
        Pilot Feasibility Stud. 2018; 4: 168
        • Dowrick CF
        • Hughes JG
        • Hiscock JJ
        • Wigglesworth M
        • Walley TJ
        Considering the case for an antidepressant drug trial involving temporary deception: A qualitative enquiry of potential participants.
        BMC Health Serv Res. 2007; 7: 64
        • Fernandes LG
        • Devan H
        • Fioratti I
        • Kamper SJ
        • Williams CM
        • Saragiotto BT
        At my own pace, space, and place: A systematic review of qualitative studies of enablers and barriers to telehealth interventions for people with chronic pain.
        Pain. 2022; 163: e165-e181
        • Fritz JM
        • Davis AF
        • Burgess DJ
        • Coleman B
        • Cook C
        • Farrokhi S
        • Goertz C
        • Heapy A
        • Lisi AJ
        • McGeary DD
        • Rhon DI
        • Taylor SL
        • Zeliadt S
        • Kerns RD
        Pivoting to virtual delivery for managing chronic pain with nonpharmacological treatments: Implications for pragmatic research.
        Pain. 2021; 162: 1591-1596
        • Gaudiano BA
        • Ellenberg SR
        • Schofield CA
        • Rifkin LS
        A randomized survey of the public’s expectancies and willingness to participate in clinical trials of antidepressants versus psychotherapy for depression.
        Prim Care Companion CNS Disord. 2016; 18https://doi.org/10.4088/PCC.15m01879
        • Gaudiano BA
        • Hughes JA
        • Miller IW
        Patients’ treatment expectancies in clinical trials of antidepressants versus psychotherapy for depression: A study using hypothetical vignettes.
        Compr Psychiatry. 2013; 54: 28-33
        • Hislop Lennie K
        • Barbosa Boucas S
        • Adams J
        • Hutt Greenyer C
        Patient and public involvement (PPI) in informing the osteoarthritis of the thumb therapy (OTTER) pilot trial: what matters most to people with thumb base osteoarthritis otter collaborations.
        Ann Rheum Dis [Internet]. 2013; 72: 778
        • Hissink Muller PCE
        • Yildiz B
        • Allaart CF
        • Brinkman DMC
        • van Rossum M
        • van Suijlekom-Smit LWA
        • van den Berg JM
        • Ten Cate R
        • de Vries MC
        Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?.
        BMC Med Ethics. 2018; 19: 96
        • Holzer KJ
        • Veasley C
        • Kerns RD
        • Edwards RR
        • Gewandter JS
        • Langford D
        • Yaeger L
        • McNicol E
        • Ferguson M
        • Turk DC
        • Dworkin RH
        • Haroutounian S
        Partnering with patients in clinical trials of pain treatments: A narrative review.
        Pain. 2022; 163: 1862-1873
        • Hood AM
        • Booker SQ
        • Morais CA
        • Goodin BR
        • Letzen JE
        • Campbell LC
        • Merriwether EN
        • Aroke EN
        • Campbell CM
        • Mathur VA
        • Janevic MR
        Confronting racism in all forms of pain research: A shared commitment for engagement, diversity, and dissemination.
        J Pain. 2022; 23: 913-928
        • Hughes-Morley A
        • Young B
        • Waheed W
        • Small N
        • Bower P
        Factors affecting recruitment into depression trials: Systematic review, meta-synthesis and conceptual framework.
        J Affect Disord. 2015; 172: 274-290
        • James J
        • Lai B
        • Witt T
        Patient engagement survey regarding future double-blinded, randomized controlled trial of tapering of chronic opioid therapy.
        J Prim Care Community Health. 2019; 10 (Thousand Oaks, California: Sage Publications Inc.N.PAG-N.PAG)
        • Janevic MR
        • Mathur VA
        • Booker SQ
        • Morais C
        • Meints SM
        • Yeager KA
        • Meghani SH
        Making pain research more inclusive: Why and how.
        J Pain. 2022; 23: 707-728
        • Leinisch-Dahlke E
        • Akova-Öztürk E
        • Bertheau U
        • Isberner I
        • Evers S
        • May A
        Patient preference in clinical trials for headache medication: the patient's view.
        Cephalalgia. 2004; 24: 347-355
        • Lenguerrand E
        • Artz N
        • Marques E
        • Sanderson E
        • Lewis K
        • Murray J
        • Parwez T
        • Bertram W
        • Beswick AD
        • Burston A
        • Gooberman-Hill R
        • Blom AW
        • Wylde V
        Effect of group-based outpatient physical therapy on function after total knee replacement: Results from a multicenter randomized controlled trial.
        Arthritis Care Res. 2020; 72: 768-777
        • Lenze SN
        • Potts MA
        Brief Interpersonal Psychotherapy for depression during pregnancy in a low-income population: A randomized controlled trial.
        J Affect Disord. 2017; 210: 151-157
        • Letzen JE
        • Mathur VA
        • Janevic MR
        • Burton MD
        • Hood AM
        • Morais CA
        • Booker SQ
        • Campbell CM
        • Aroke EN
        • Goodin BR
        • Campbell LC
        • Merriwether EN
        Confronting racism in all forms of pain research: Reframing study designs.
        J Pain. 2022; 23: 893-912
        • Middleton LJ
        • Daniels JP
        • Weckesser A
        • Bhattacharya S
        PRE-EMPT trial collaborative group. Preventing recurrence of endometriosis by means of long-acting progestogen therapy (PRE-EMPT): report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitment.
        Trials. 2017; 18: 121
        • Midgley N
        • Isaacs D
        • Weitkamp K
        • Target M
        The experience of adolescents participating in a randomised clinical trial in the field of mental health: a qualitative study.
        Trials. 2016; 17: 364
        • Morais CA
        • Aroke EN
        • Letzen JE
        • Campbell CM
        • Hood AM
        • Janevic MR
        • Mathur VA
        • Merriwether EN
        • Goodin BR
        • Booker SQ
        • Campbell LC
        Confronting racism in pain research: A call to action.
        J Pain. 2022; (S1526590022000293)
        • Morgan EM
        • Munro JE
        • Horonjeff J
        • Horgan B
        • Shea B
        • Feldman BM
        • Clairman H
        • Bingham 3rd, CO
        • Thornhill S
        • Strand V
        • Alongi A
        • Magni-Manzoni S
        • van Rossum MAJ
        • Vesely R
        • Vojinovic J
        • Brunner HI
        • Harris JG
        • Horton DB
        • Lovell DJ
        • Mannion M
        • Rahimi H
        • Ravelli A
        • Ringold S
        • Ruperto N
        • Schrandt MS
        • Shenoi S
        • Shiff NJ
        • Toupin-April K
        • Tzaribachev N
        • Weiss P
        • Consolaro A
        Establishing an updated core domain set for studies in juvenile idiopathic arthritis: A report from the OMERACT 2018 JIA workshop.
        J Rheumatol Canada;. 2019; 46: 1006-1013
        • Munn Z
        • Peters MDJ
        • Stern C
        • Tufanaru C
        • McArthur A
        • Aromataris E
        Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach.
        BMC Med Res Methodol. 2018; 18: 143
        • Nelson A
        • Fenlon D
        • Morris J
        • Sampson C
        • Harrop E
        • Murray N
        • Wheatley D
        • Hood K
        • Griffiths G
        • Barrett-Lee P
        QUALZICE: A QUALitative exploration of the experiences of the participants from the ZICE clinical trial (metastatic breast cancer) receiving intravenous or oral bisphosphonates.
        Trials. 2013; 14 (325–325)
        • O'Cathain A
        • Thomas KJ
        • Drabble SJ
        • Rudolph A
        • Hewison J
        What can qualitative research do for randomised controlled trials? A systematic mapping review.
        BMJ Open. 2013; 3e002889
        • Paterson C
        • Zheng Z
        • Xue C
        • Wang Y
        Playing their parts”: The experiences of participants in a randomized sham-controlled acupuncture trial.
        J Altern Complement Med. 2008; 14 (New Rochelle, New York: Mary Ann Liebert, Inc.): 199-208
        • Sheridan R
        • Martin-Kerry J
        • Hudson J
        • Parker A
        • Bower P
        • Knapp P
        Why do patients take part in research? An overview of systematic reviews of psychosocial barriers and facilitators.
        Trials. 2020; 21: 259
        • Sherratt FC
        • Roper L
        • Baildam E
        • Beresford MW
        • Stones SR
        • Ramanan A
        • Foster H
        • McErlane F
        • Rooney M
        • Peak M
        • Young B
        Families’ views on the feasibility of a corticosteroid trial in JIA: A qualitative study.
        Pediatr Rheumatol. 2017; 15: 132
        • Smith SM
        • Gewandter JS
        • Kitt RA
        • Markman JD
        • Vaughan JA
        • Cowan P
        • Kopecky EA
        • Malamut R
        • Sadosky A
        • Tive L
        • Turk DC
        • Dworkin RH
        Participant preferences for pharmacologic chronic pain treatment trial characteristics: An ACTTION adaptive choice-based conjoint study.
        J Pain United States;. 2016; 17: 1198-1206
        • Stamuli E
        • Torgerson D
        • Northgraves M
        • Ronaldson S
        • Cherry L
        Identifying the primary outcome for a randomised controlled trial in rheumatoid arthritis: the role of a discrete choice experiment.
        J Foot Ankle Res. 2017; 10: 57
        • Tallon D
        • Mulligan J
        • Wiles N
        • Thomas L
        • Peters TJ
        • Elgie R
        • Sharp D
        • Lewis G
        Involving patients with depression in research: Survey of patients’ attitudes to participation.
        Br J Gen Pract. 2011; 61: e134-e141
        • Taylor WJ
        • Brown M
        • Aati O
        • Weatherall M
        • Dalbeth N
        Do patient preferences for core outcome domains for chronic gout studies support the validity of composite response criteria?.
        Arthritis Care Res United States. 2013; 65: 1259-1264
        • Tricco AC
        • Lillie E
        • Zarin W
        • O'Brien KK
        • Colquhoun H
        • Levac D
        • Moher D
        • Peters MDJ
        • Horsley T
        • Weeks L
        • Hempel S
        • Akl EA
        • Chang C
        • McGowan J
        • Stewart L
        • Hartling L
        • Aldcroft A
        • Wilson MG
        • Garritty C
        • Lewin S
        • Godfrey CM
        • Macdonald MT
        • Langlois EV
        • Soares-Weiser K
        • Moriarty J
        • Clifford T
        • Ö Tunçalp
        • Straus SE
        PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation.
        Ann Intern Med. 2018; 169: 467-473
        • Turk DC
        • Dworkin RH
        • Revicki D
        • Harding G
        • Burke LB
        • Cella D
        • Cleeland CS
        • Cowan P
        • Farrar JT
        • Hertz S
        • Max MB
        • Rappaport BA
        Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain.
        Pain United States;. 2008; 137: 276-285
        • Vercellini P
        • Somigliana E
        • Cortinovis I
        • Bracco B
        • de Braud L
        • Dridi D
        • Milani S
        “You can't always get what you want”: from doctrine to practicability of study designs for clinical investigation in endometriosis.
        BMC Womens Health BioMed Central;. 2015; 15: 1-9
        • Verhaart IEC
        • Johnson A
        • Thakrar S
        • Vroom E
        • De Angelis F
        • Muntoni F
        • Aartsma-Rus AM
        • Niks EH
        Muscle biopsies in clinical trials for Duchenne muscular dystrophy - Patients’ and caregivers’ perspective.
        Neuromuscul Disord NMD England;. 2019; 29: 576-584
        • Wasmann KA
        • Wijsman P
        • van Dieren S
        • Bemelman W
        • Buskens C
        Partially randomised patient preference trials as an alternative design to randomised controlled trials: systematic review and meta-analyses.
        BMJ Open. 2019; 9e031151
        • Wu D
        Patient preference of pain measurements: a cross-sectional study based on chronic low back pain population in china.
        J Altern Complement Med N Y N. 2016; 22: A139
        • Basics about clinical trials [Internet]
        U.S. Food & Drug Administration.
        FDA, 2014 ([cited 2022 Jan 7]. Available from:) (Accessed November 14, 2022)
      1. Clinical Trials: The Heart and Soul of Science [Internet]. The Louisiana Community Engagement Alliance against COVID-19 Disparities (LA-CEAL) [cited 2022 Jun 15]. Available from: https://www.youtube.com/watch?v=5j8Ppc4Ti8w. Accessed November 14, 2022.

      2. Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist [Internet].
        PRISMA, 2021 ([cited 2021 Nov 2]. Available from:) (Accessed November 14, 2022)
        • The Voice of the Patient. Sickle Cell Disease [Internet]
        US Food and Drug Administration, Patient-Focused Drug Development Initiative.
        FDA, 2014 Oct (Available from:) (Accessed November 14, 2022)